Cargando…

Adrenal Incidentalomas and Other Endocrine-Related Adenomas: How Much Does Cortisol Secretion Matter?

SIMPLE SUMMARY: This article reflects a comprehensive analysis between cortisol secretion and the presence of other endocrine-related adenomas (specifically thyroid, parathyroid and pituitary). Cortisol has anti-inflammatory properties but has also been related to impaired cell proliferation and fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera-Martínez, Aura D., Rebollo Román, Ángel, Pascual Corrales, Eider, Idrobo, Cindy, Parra Ramírez, Paola, Martín Rojas-Marcos, Patricia, Robles Lázaro, Cristina, Marginean, Delia Lavinia, Araujo-Castro, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572012/
https://www.ncbi.nlm.nih.gov/pubmed/37835429
http://dx.doi.org/10.3390/cancers15194735
_version_ 1785120136482521088
author Herrera-Martínez, Aura D.
Rebollo Román, Ángel
Pascual Corrales, Eider
Idrobo, Cindy
Parra Ramírez, Paola
Martín Rojas-Marcos, Patricia
Robles Lázaro, Cristina
Marginean, Delia Lavinia
Araujo-Castro, Marta
author_facet Herrera-Martínez, Aura D.
Rebollo Román, Ángel
Pascual Corrales, Eider
Idrobo, Cindy
Parra Ramírez, Paola
Martín Rojas-Marcos, Patricia
Robles Lázaro, Cristina
Marginean, Delia Lavinia
Araujo-Castro, Marta
author_sort Herrera-Martínez, Aura D.
collection PubMed
description SIMPLE SUMMARY: This article reflects a comprehensive analysis between cortisol secretion and the presence of other endocrine-related adenomas (specifically thyroid, parathyroid and pituitary). Cortisol has anti-inflammatory properties but has also been related to impaired cell proliferation and function. Specifically, its role in the presence of other benign lesions has not been described. For these reasons, we analyzed the prevalence of these other endocrine-related benign lesions in patients with nonfunctioning adrenal incidentalomas and with mild autonomous cortisol secretion. We observed that mild autonomous hypercortisolism does not affect the prevalence of other endocrine-related adenomas but is associated with increased metabolic comorbidities and mortality in these patients. ABSTRACT: Background: Adrenal incidentalomas (AI) are frequent findings in clinical practice. About 40% of AIs are associated with hypercortisolism of variable severity. Although mild autonomous cortisol secretion (MACS) has been associated with the impaired clinical outcome of several diseases, its effect on the development of benign neoplasms is unknown. Aim: To compare the prevalence of adenomas (thyroid, parathyroid, pituitary and other locations) in patients with nonfunctioning AIs (NFAIs) and MACS. Methods: A multicenter, retrospective study of patients with AIs evaluated in four tertiary hospitals was performed. Results: A total of 923 patients were included. Most patients were male (53.6%), with a mean age at diagnosis of 62.4 ± 11.13 years; 21.7% presented with bilateral AIs. MACS was observed in 29.9% (n = 276) of patients, while 69.9% (n = 647) were NFAIs. Adenomas in locations other than the adrenal gland were observed in 36% of the studied population, with a similar distribution in patients with MACS and NFAIs (33% vs. 32%; p > 0.05). There were no statistically significant differences in the prevalence of pituitary, thyroid, parathyroid or other endocrine-related adenomas between both groups, but the prevalence of metabolic comorbidities and mortality was increased in patients with MACS, specifically in patients with thyroid and other endocrine-related adenomas (p < 0.05). Conclusions: Adenomas in locations other than the adrenal glands occur in one third of patients with AIs. Mild autonomous hypercortisolism does not affect the prevalence of other endocrine-related adenomas but is associated with increased metabolic comorbidities and mortality, especially in patients with thyroid adenomas and adenomas in other locations.
format Online
Article
Text
id pubmed-10572012
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105720122023-10-14 Adrenal Incidentalomas and Other Endocrine-Related Adenomas: How Much Does Cortisol Secretion Matter? Herrera-Martínez, Aura D. Rebollo Román, Ángel Pascual Corrales, Eider Idrobo, Cindy Parra Ramírez, Paola Martín Rojas-Marcos, Patricia Robles Lázaro, Cristina Marginean, Delia Lavinia Araujo-Castro, Marta Cancers (Basel) Article SIMPLE SUMMARY: This article reflects a comprehensive analysis between cortisol secretion and the presence of other endocrine-related adenomas (specifically thyroid, parathyroid and pituitary). Cortisol has anti-inflammatory properties but has also been related to impaired cell proliferation and function. Specifically, its role in the presence of other benign lesions has not been described. For these reasons, we analyzed the prevalence of these other endocrine-related benign lesions in patients with nonfunctioning adrenal incidentalomas and with mild autonomous cortisol secretion. We observed that mild autonomous hypercortisolism does not affect the prevalence of other endocrine-related adenomas but is associated with increased metabolic comorbidities and mortality in these patients. ABSTRACT: Background: Adrenal incidentalomas (AI) are frequent findings in clinical practice. About 40% of AIs are associated with hypercortisolism of variable severity. Although mild autonomous cortisol secretion (MACS) has been associated with the impaired clinical outcome of several diseases, its effect on the development of benign neoplasms is unknown. Aim: To compare the prevalence of adenomas (thyroid, parathyroid, pituitary and other locations) in patients with nonfunctioning AIs (NFAIs) and MACS. Methods: A multicenter, retrospective study of patients with AIs evaluated in four tertiary hospitals was performed. Results: A total of 923 patients were included. Most patients were male (53.6%), with a mean age at diagnosis of 62.4 ± 11.13 years; 21.7% presented with bilateral AIs. MACS was observed in 29.9% (n = 276) of patients, while 69.9% (n = 647) were NFAIs. Adenomas in locations other than the adrenal gland were observed in 36% of the studied population, with a similar distribution in patients with MACS and NFAIs (33% vs. 32%; p > 0.05). There were no statistically significant differences in the prevalence of pituitary, thyroid, parathyroid or other endocrine-related adenomas between both groups, but the prevalence of metabolic comorbidities and mortality was increased in patients with MACS, specifically in patients with thyroid and other endocrine-related adenomas (p < 0.05). Conclusions: Adenomas in locations other than the adrenal glands occur in one third of patients with AIs. Mild autonomous hypercortisolism does not affect the prevalence of other endocrine-related adenomas but is associated with increased metabolic comorbidities and mortality, especially in patients with thyroid adenomas and adenomas in other locations. MDPI 2023-09-26 /pmc/articles/PMC10572012/ /pubmed/37835429 http://dx.doi.org/10.3390/cancers15194735 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Herrera-Martínez, Aura D.
Rebollo Román, Ángel
Pascual Corrales, Eider
Idrobo, Cindy
Parra Ramírez, Paola
Martín Rojas-Marcos, Patricia
Robles Lázaro, Cristina
Marginean, Delia Lavinia
Araujo-Castro, Marta
Adrenal Incidentalomas and Other Endocrine-Related Adenomas: How Much Does Cortisol Secretion Matter?
title Adrenal Incidentalomas and Other Endocrine-Related Adenomas: How Much Does Cortisol Secretion Matter?
title_full Adrenal Incidentalomas and Other Endocrine-Related Adenomas: How Much Does Cortisol Secretion Matter?
title_fullStr Adrenal Incidentalomas and Other Endocrine-Related Adenomas: How Much Does Cortisol Secretion Matter?
title_full_unstemmed Adrenal Incidentalomas and Other Endocrine-Related Adenomas: How Much Does Cortisol Secretion Matter?
title_short Adrenal Incidentalomas and Other Endocrine-Related Adenomas: How Much Does Cortisol Secretion Matter?
title_sort adrenal incidentalomas and other endocrine-related adenomas: how much does cortisol secretion matter?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572012/
https://www.ncbi.nlm.nih.gov/pubmed/37835429
http://dx.doi.org/10.3390/cancers15194735
work_keys_str_mv AT herreramartinezaurad adrenalincidentalomasandotherendocrinerelatedadenomashowmuchdoescortisolsecretionmatter
AT rebolloromanangel adrenalincidentalomasandotherendocrinerelatedadenomashowmuchdoescortisolsecretionmatter
AT pascualcorraleseider adrenalincidentalomasandotherendocrinerelatedadenomashowmuchdoescortisolsecretionmatter
AT idrobocindy adrenalincidentalomasandotherendocrinerelatedadenomashowmuchdoescortisolsecretionmatter
AT parraramirezpaola adrenalincidentalomasandotherendocrinerelatedadenomashowmuchdoescortisolsecretionmatter
AT martinrojasmarcospatricia adrenalincidentalomasandotherendocrinerelatedadenomashowmuchdoescortisolsecretionmatter
AT robleslazarocristina adrenalincidentalomasandotherendocrinerelatedadenomashowmuchdoescortisolsecretionmatter
AT margineandelialavinia adrenalincidentalomasandotherendocrinerelatedadenomashowmuchdoescortisolsecretionmatter
AT araujocastromarta adrenalincidentalomasandotherendocrinerelatedadenomashowmuchdoescortisolsecretionmatter